CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease

NCT03618641 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Lymph Node Cancer

Interventions

DRUG: CMP-001
BIOLOGICAL: Nivolumab

Sponsor

Diwakar Davar

Collaborators

[object Object]